

Tuesday 17 March
10:00-10:30
Registration & welcome coffee
10:30-12:15
Session 1: AAV vector manufacturing
Chairs: ​
10:30 Welcome & sponsor presentation
​
10:40 Eduard Ayuso, Dinamiqs
​INV01: Title TBC​
11:10 Selected abstract
11:25 Selected abstract
11:40 Selected abstract
​
11:55 Poster pitches (10 x 2 min)​
12:30-13:15
Lunch
13:15-14:00
Poster session
14:00-15:20
Session 2: AAV vector efficacy
Chairs:
​
14:00 Sponsor presentation
​
14:05 Thierry VandenDriessche, VUB, Brussels
INV02: Title TBC
​
14:35 Selected abstract
14:50 Selected abstract
15:05 Selected abstract​
15:20-15:45
Coffee break and posters
15:45-17:05
Session 3: AAV vector safety
Chairs:
​
15:45 Sponsor presentation
​
15:50 Gwladys Gernoux, Nantes
INV03: Title TBC
​
16:20 Selected abstract
16:35 Selected abstract
16:50 Selected abstract​
17:05-17:15
Closing and awards
17:15-18:00
Closing drinks
18:00-19:30
Table ronde, avec les associations de patients et échanges avec les experts du domaine
- Coût des thérapies géniques et cellulaires
- Accessibilité des thérapies
- Processus de mise sur le marché
